School of Pharmacy UNIVERSITY OF WISCONSIN - MADISON Educational Support Zografi Educational Advancement Fund The George D. Zografi Educational Advancement Fund in Pharmaceutical Sciences was established to honor the distinguished career of Professor Zografi upon his retirement. The “Zografi Fund” supports undergraduate, graduate and professional students who are pursuing industry-based laboratory research projects directly linked with the Zeeh Pharmaceutical Experiment Station. This educational support is intended to encourage and advance student activities related to pharmaceutical research and development of drug products at and beyond the UW–Madison, School of Pharmacy. To make a contribution, please click on any of the following links: GIVE ONLINE: Zografi Educational Advancement Fund GIVE ONLINE: Zeeh Pharmaceutical Experiment Station Fund GIVE ONLINE: School of Pharmacy Annual Fund Professor Zografi, the School of Pharmacy and the STATION wish to thank and acknowledge those who have made generous gifts to assist in the establishment and ongoing support of the Zografi Fund. Donor List – Zografi Educational Fund Student Support Provided by the Zografi Fund Alexa Barres – Research Assistant (Spring 2019) Pawel Zbyszynski – Research Assistant (Summer 2018) Zhenxuan Chen – Research Assistant (Summer 2017) Yinshan Chen – Research Assistant (Summer 2015) Rattavut “M” Terrakapibal – Research Assistant (Summer 2013, Fall 2013) Tyler Matzinger – Student Research Assistant (Summer 2012) Elham Nejati – Research Assistant (Fall 2011) Thomas A Diezi – Research Assistant (Summer 2008 & Summer 2009) Dr. George Zografi Dr. George Zografi is currently professor emeritus of Pharmaceutical Sciences at the UW- Madison. He is a prominent educator and researcher, and served as Dean of the School of Pharmacy from 1975-1980. Dr. Zografi was a key advocate for the re-establishment of the STATION based on his passion for ensuring the continued effective application of the physical sciences and pharmaceutics to the development of drug products, at a time when industry must fill pharmaceutical development positions with chemists and engineers due to the lack of available pharmacy-trained scientists.